Back to search

Article

Aspirin prescribing in cardiovascular disease in middle-aged and older adults in Ireland: findings from The Irish Longitudinal Study on Ageing

2020-07-27

Abstract excerpt

<h4>Background</h4> Aspirin use for cardiovascular indications is widespread despite evidence not supporting use in patients without cardiovascular disease (CVD). This study characterises aspirin prescribing among people aged ≥50 years in Ireland for primary and secondary prevention, and factors associated with prescription. <h4>Methods</h4> This cross-sectional study includes participants from wave 3 (2014-2015)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5ff3af4b-6dab-5df4-8335-72474ec2c9f0
DOI
10.1101/2020.07.24.20161703
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aspirin prescribing in cardiovascular disease in middle-aged and older adults in Ireland: findings from The Irish Longitudinal Study on AgeingDOI 10.1101/2020.07.24.20161703
Statin Therapy and Stroke Risk in Patients with Hypercholesterolaemia: A population-based Longitudinal Study Using Electronic Health Records in South LondonSemantic proximity
Myocardial infarction as the first manifestation of atherosclerotic diseaseSemantic proximity
Stroke rates, risk factors, and aspirin prescribing trends in the Canadian Fabry Disease Initiative cohortSemantic proximity
Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: A longitudinal cohort studySemantic proximity
Distribution of cardiovascular disease risk based on the updated 2023 guideline-recommended Australian cardiovascular disease risk algorithm and comparison with the 2012 algorithmSemantic proximity
General Practitioners’ adherence to prescribing guidelines for statins in the United KingdomsSemantic proximity
Investigating doctors' involvement to ACC/AHA 2018 blood cholesterol treatment recommendations at Al-Qurryyat General Hospital, in Northern Saudi ArabiaSemantic proximity
Association between prescription drugs and all-cause mortality risk in the UK populationSemantic proximity
The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale analysis of trends in medication dataSemantic proximity
Long-term Effectiveness of PCSK9 Inhibitors versus Ezetimibe as Adjunctive Therapy to Statins in Patients with Atherosclerotic Cardiovascular Disease: A TriNetX Database AnalysisSemantic proximity
Precision Anti-Inflammatory Therapy in Atherosclerosis: A Systematic Review and Meta-Analysis of Colchicine Timing and Clinical Outcomes in Patients with Atherosclerotic Cardiovascular DiseaseSemantic proximity
Liraglutide Use in A Real-World Setting: Patient Characteristics at Antidiabetic Treatment Initiation Modulate Cardiovascular Safety OutcomesSemantic proximity
Select a neighboring publication to make it the new centre.